MedCity News January 18, 2021
In this article, experts forecast upcoming AI developments that will help shape a new commercial model, making 2021 the year when AI shifts from early exploration to broad adoption.
Artificial Intelligence (AI) is no longer a ‘nice-to-have’ in life sciences today, especially with increasing pricing pressures, global competition, and operational complexity. Even Covid-19 has not dampened the AI fire as 38% of technology leaders report that their AI investment plans are unchanged, and one-third (32%) say the pandemic has accelerated their plans.
For more than a decade, the industry struggled to get its volumes of data – the fuel for all AI engines – in order, working to gather it all from across different places, often confined in spreadsheets...
Today's Sponsors
Today's Sponsor